Received: 17 December 2020
Accepted: 21 January 2021
First Online: 6 February 2021
Compliance with ethical standards
: The authors declare no conflict of interest related to this study, including connections to the pharmaceutical agencies. Connections with pharmaceutical companies NOT related to this study: Nelly Ziade: Speaker’s honoraria (Roche, Abbvie, Eli Lilly, Pfizer, Janssen, Novartis, Pierre Fabre, Apotex, Pharmaline), Internal workshops (Abbvie, Eli Lilly, Sanofi-Aventis, Pfizer, Janssen), Advisory boards (Roche, Abbvie, Eli Lilly, Pfizer, Janssen, Novartis, Gilead, NewBridge), Research grants (Abbvie, NewBridge, Algorithm/Celgene). Sahar Saad: none declared. Manal Al Mashaleh: none declared. Lina el-Kibbi: Research grant (Lilly). Bassel el-Zorkany: Consultancy, Research Grants and Advisory and speakers’ honoraria for: Abbott, Abbvie, Amgen, Aspire, BMS, Hekma, Janssen, Lilly, MSD, New Bridge, Novartis, Pfizer, Roche, Sanofi-Aventis, Servier, UCB. Humeira Badsha: Speaker’s honoraria (Lilly, Abbvie, Pfizer, Janssen, Novartis Gilead), Advisory board meetings (Lilly, Abbvie, Novartis, Pfizer Gilead); Research grants (Pfizer and Lilly). Ghita Harifi: Speaker fees (Lilly, Abbvie, Pfizer, Janssen, Novartis), Advisory board meetings (Lilly, Abbvie, Novartis, Pfizer), Research grants (Pfizer, Lilly). Amani Daher: non declared. Nelly Salloum: none declared. Basel Masri: Speaker’s honoraria (Amgen, Novo Nordisk, Novartis), Advisory board (Amgen). Thurayya Arayssi: none declared.
: The study complies with the Declaration of Helsinki. The Ethics Committee of Saint-Joseph University, Beirut has approved the research protocol (Tfem2018/24).
: Written informed consent has been obtained from the subjects prior to inclusion in the study.
: All the authors have given consent for publication.
Free to read: This content has been made available to all.